Pfizer CEO: Trump, Kennedy Sympathetic To ‘Pill Penalty’ Concerns

Pfizer CEO Albert Bourla says both President Donald Trump and HHS Secretary Robert F. Kennedy Jr. have shown sympathy towards the pharmaceutical industry's concerns regarding the Inflation Reduction Act's (IRA) "pill penalty" provision, which pharma lobbyists argue discourages research into small molecule drugs. "It's something that we discussed with the administration. I think they are sympathetic to it, both the president and the secretary. But I don't know if that could be achieved or not,” Bourla, who is now the...